Joy Lipka

801 total citations
9 papers, 658 citations indexed

About

Joy Lipka is a scholar working on Infectious Diseases, Molecular Biology and Pharmacology. According to data from OpenAlex, Joy Lipka has authored 9 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 2 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Joy Lipka's work include Antifungal resistance and susceptibility (2 papers), Bacterial biofilms and quorum sensing (2 papers) and Antimicrobial Resistance in Staphylococcus (2 papers). Joy Lipka is often cited by papers focused on Antifungal resistance and susceptibility (2 papers), Bacterial biofilms and quorum sensing (2 papers) and Antimicrobial Resistance in Staphylococcus (2 papers). Joy Lipka collaborates with scholars based in United States, India and Chile. Joy Lipka's co-authors include Carole A. Sable, Irinel Popescu, M Ramesh, Christopher Lucasti, David Stricklin, Dipesh D Duttaroy, José Antonio Vázquez, Nicholas A. Kartsonis, Robert F. Betts and Clayton Harro and has published in prestigious journals such as The Journal of Infectious Diseases, Journal of Antimicrobial Chemotherapy and Vaccine.

In The Last Decade

Joy Lipka

9 papers receiving 649 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joy Lipka United States	8	340	287	269	195	147	9	658
Luis Alberto Rodríguez Arroyo Spain	7	439 1.3×	342 1.2×	134 0.5×	46 0.2×	58 0.4×	15	776
Angella Charnot‐Katsikas United States	15	428 1.3×	228 0.8×	114 0.4×	242 1.2×	116 0.8×	30	940
Areli Martínez‐Gamboa Mexico	13	164 0.5×	318 1.1×	43 0.2×	366 1.9×	119 0.8×	32	622
A Kazmierczak France	13	230 0.7×	206 0.7×	179 0.7×	134 0.7×	28 0.2×	47	477
E Vallée France	16	266 0.8×	419 1.5×	307 1.1×	157 0.8×	30 0.2×	31	642
Maria Exindari Greece	12	122 0.4×	263 0.9×	40 0.1×	221 1.1×	54 0.4×	42	580
Zi-Ke Sheng China	15	505 1.5×	167 0.6×	138 0.5×	86 0.4×	40 0.3×	32	802
Federico Román Spain	15	285 0.8×	495 1.7×	109 0.4×	110 0.6×	26 0.2×	29	790
A. Tarasi Italy	12	291 0.9×	261 0.9×	162 0.6×	165 0.8×	84 0.6×	31	607
Pedro Torres‐González Mexico	11	124 0.4×	219 0.8×	29 0.1×	247 1.3×	55 0.4×	29	450

Countries citing papers authored by Joy Lipka

Since Specialization

Citations

This map shows the geographic impact of Joy Lipka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joy Lipka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joy Lipka more than expected).

Fields of papers citing papers by Joy Lipka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joy Lipka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joy Lipka. The network helps show where Joy Lipka may publish in the future.

Co-authorship network of co-authors of Joy Lipka

This figure shows the co-authorship network connecting the top 25 collaborators of Joy Lipka. A scholar is included among the top collaborators of Joy Lipka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joy Lipka. Joy Lipka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Cassino, Cara, Anita Das, & Joy Lipka. (2021). LB12. Exebacase Shows Rapid Symptom Resolution in a Phase 2 Study in Adult Patients with Staphylococcus aureus bacteremia. Open Forum Infectious Diseases. 8(Supplement_1). S811–S811. 1 indexed citations

Lucasti, Christopher, Irinel Popescu, M Ramesh, Joy Lipka, & Carole A. Sable. (2013). Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial. Journal of Antimicrobial Chemotherapy. 68(5). 1183–1192. 193 indexed citations

Vázquez, José Antonio, et al.. (2012). Efficacy and safety of ceftazidime–avibactam versus imipenem–cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study. Current Medical Research and Opinion. 28(12). 1921–1931. 185 indexed citations

Harro, Clayton, Robert F. Betts, Jonathan Hartzel, et al.. (2011). The immunogenicity and safety of different formulations of a novel Staphylococcus aureus vaccine (V710): Results of two Phase I studies. Vaccine. 30(9). 1729–1736. 46 indexed citations

Harro, Clayton, Robert F. Betts, Walter A. Orenstein, et al.. (2010). Safety and Immunogenicity of a Novel Staphylococcus aureus Vaccine: Results from the First Study of the Vaccine Dose Range in Humans. Clinical and Vaccine Immunology. 17(12). 1868–1874. 46 indexed citations

Cornely, Oliver A., Martín Lasso, Robert F. Betts, et al.. (2007). Caspofungin for the treatment of less common forms of invasive candidiasis. Journal of Antimicrobial Chemotherapy. 60(2). 363–369. 99 indexed citations

Zibari, Gazi B., et al.. (2000). The use of contaminated donor organs in transplantation. Clinical Transplantation. 14(4). 397–400. 42 indexed citations

Lipka, Joy, et al.. (1998). Spontaneous bacterial peritonitis in liver failure.. PubMed. 64(12). 1155–7. 8 indexed citations

Buckner, Cindy M., Chester R. Roberts, Steven K. H. Foung, et al.. (1992). Immune Responsiveness to the Immunodominant Recombinant Envelope Epitopes of Human T Lymphotropic Virus Types I and II in Diverse Geographic Populations. The Journal of Infectious Diseases. 166(5). 1160–1163. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact